Course Overview


Save the Date: This course will be offered again on September 25-30, 2016

2016 information coming soon. 


Comprehensive Updates and Practice Recommendations to Optimize Patient Care and Outcomes

Recent advances in cancer medicine and hematology have significant implications for clinicians. Participation in this special CME program ensures you are current with updates and innovations in the following areas and the best ways to integrate them into practice: 

  • Familial syndromes
  • Personalized oncologic management
  • Targeted therapies
  • Symptom control
  • Treating hypercoagulable conditions
  • Using novel anticoagulants
  • Immune therapy
  • Management of cancer survivors
  • Palliative care

Participants may also join a special workshop for ABIM Maintenance of Certification (MOC): the 2015 Update in Medical Oncology Module, on the evening of Tuesday, Sept. 29.

The curriculum covers a wide spectrum of conditions including: cancers of the breast, lung, head and neck; gastrointestinal, genitourinary and gynecologic cancers; malignant and benign hematologic disorders; melanoma; thrombotic disorders; and less common cancers, including brain, thyroid, sarcoma, and mesothelioma.

The best patient care and outcomes require us to stay current with these changes and incorporate them into practice. Year after year, attendees of this program report that the week they spent out of their offices, updating and advancing their skills, proved invaluable to them and their patients.

Additional coverage areas in the 2015 curriculum include the latest in:

  • Transfusion medicine for the clinician
  • Molecular genetics of cancer
  • Advances in cancer drug development
  • Infections in the immunocompromised host
  • Myelodyplastic and myeloproliferative syndromes
  • Neoplasm, lymphoma and Hodgkin's disease
  • Genetics, screening and treatment of gastrointestinal malignancies
  • Neuro-oncology
  • Management of metastatic disease
  • Breast cancer: advances in staging, prognosis, surgery and radiation
  • Small cell and non-small cell lung cancer

Attendees will also enjoy a special networking dinner at the Harvard Club, featuring keynote insights from bioethicist Dr. Ezekiel J. Emanuel of the University of Pennsylvania and the Center for American Progress. He will be speaking about megatrends and the future of American health care, and its implications for practitioners.